The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…